E
Summit Therapeutics Inc. SMMT
$23.96 -$0.69-2.80% NASDAQ
Recommendation
Prev Close
$23.96
Volume
17,261
Avg Vol (90D)
3,479,807
Market Cap
$17.79B
Dividend & Yield
--
52-Week Range
$2.10 - $36.91
P/E (TTM)
--
EPS (TTM)
-$0.3496
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Summit Therapeutics Inc. (NASDAQ:SMMT) Receives Average Rating of "Buy" from Analysts
5/12/2025 - MarketBeat
Granahan Investment Management LLC Purchases 7,734 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT)
5/11/2025 - Ticker Report
Summit Therapeutics Inc. (NASDAQ:SMMT) Shares Sold by Balyasny Asset Management L.P.
5/10/2025 - Ticker Report
Summit Therapeutics (SMMT, $23.96) entered Uptrend as Momentum indicator ascends above 0 level on May 09, 2025
5/10/2025 - Tickeron - Technical Analysis
Summit Therapeutics Inc. (SMMT): Among the Best Cancer Stocks to Invest in for Long-Term Gain
5/9/2025 - Insider Monkey
Summit Therapeutics Inc. (SMMT): Among the Best Cancer Stocks to Invest in for Long-Term Gain
5/9/2025 - Yahoo! Finance: News
Summit Therapeutics Inc. (NASDAQ:SMMT) Shares Sold by Bosun Asset Management LLC
5/9/2025 - MarketBeat
Summit Therapeutics (SMMT) Receives Positive Coverage from TD Cowen SMMT Stock News
5/8/2025 - GuruFocus
Summit Therapeutics initiated with a Buy at TD Cowen
5/8/2025 - TipRanks Financial Blog
Summit Therapeutics initiated with bullish view at TD Cowen, here's why
5/8/2025 - The Fly
Summit Therapeutics (SMMT, $24.29) Stochastic Oscillator left the oversold zone on May 07, 2025
5/8/2025 - Tickeron - Stocks
Can Summit Therapeutics Stock Double Your Money?
5/7/2025 - Fool.com Headlines
Summit Therapeutics Inc. (NASDAQ:SMMT) Shares Sold by Bosun Asset Management LLC
5/7/2025 - Ticker Report
Bayesian Capital Management LP Invests $1.20 Million in Summit Therapeutics Inc. (NASDAQ:SMMT)
5/7/2025 - MarketBeat
Summit Therapeutics (SMMT, $24.2) entered Downtrend as Momentum indicator drops below 0 level on May 06, 2025
5/7/2025 - Tickeron - Technical Analysis
Wall Street Analysts Predict a 33.4% Upside in Summit Therapeutics (SMMT): Here's What You Should Know
5/6/2025 - Zacks Investment Research
Analysts See 16% Upside For ILCB
5/6/2025 - ETF Channel
Bellevue Group AG Has $3.04 Million Stock Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT)
5/6/2025 - MarketBeat
Summit Therapeutics (SMMT, $28.02) Stochastic Oscillator left the oversold zone on May 05, 2025
5/6/2025 - Tickeron - Technical Analysis
Summit Therapeutics (NASDAQ:SMMT) Issues Quarterly Earnings Results
5/5/2025 - MarketBeat
Summit Therapeutics (NASDAQ:SMMT) Issues Earnings Results
5/5/2025 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), Alkermes (ALKS) and Summit Therapeutics (SMMT)
5/5/2025 - TipRanks Financial Blog
Summit Therapeutics (NASDAQ:SMMT) Trading 16.9% Higher After Better-Than-Expected Earnings
5/4/2025 - MarketBeat
250,000 Shares in Summit Therapeutics Inc. (NASDAQ:SMMT) Acquired by Boxer Capital Management LLC
5/4/2025 - MarketBeat
Why Summit Therapeutics Inc. (SMMT) Soared Last Week
5/4/2025 - Yahoo! Finance: News
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$235.37M
EBIT (TTM)
-$235.45M
Net Income (TTM)
-$240.76M
Balance Sheet
Total Assets (Q)
$383.82M
Total Debt (Q)
$6.45M
Total Liabilities (Q)
$39.49M
Book Value Per Share (Q)
$0.4643
Cash Flow
Cash from Operations (TTM)
-$173.14M
Cash from Investing (TTM)
-$65.10M
Cash from Financing (TTM)
$388.42M
Net Change in Cash (TTM)
$150.23M
Filings
Filing Date
Thursday, May 1, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
0.43
7-Day Total Return
-2.88%
30-Day Total Return
17.91%
60-Day Total Return
9.81%
90-Day Total Return
33.93%
Year to Date Total Return
30.57%
1-Year Total Return
415.27%
2-Year Total Return
1,030.19%
3-Year Total Return
2,039.29%
5-Year Total Return
594.49%
52-week Low
May 28, 2024 - $2.10
52-week High
Apr 24, 2025 - $36.91
Valuation
Market Cap
$17.79B - Large Cap
Enterprise Value
$17.44B
Price/Sales (TTM)
--
Price/Book (Q)
51.60
Dividends and Shares
Shares Outstanding
738.08M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.smmttx.com
Phone Number
305-203-2034
Address
601 Brickell Key Drive
Miami, FL 33131
Country
United States
Year Founded
2003
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its... more
NASDAQ 05/09/2025 4:00PM Eastern Quotes delayed